Endovascular thrombectomy versus medical management for basilar artery occlusion stroke with mild neurological deficit - results from the BASILAR registry.

Neurol ResSep 13, 2025 (epub)

Zhenyu Kong, Liang Ye, Hong Wang et al.

✦ AI-curated · Sources linked

In 30 seconds

This comparative analysis examined endovascular thrombectomy (EVT) plus medical management versus medical management alone in acute basilar artery occlusion with mild neurological deficits (NIHSS ≤10). It included 98 patients from the BASILAR registry, adjusted for baseline differences using inverse probability weighting, and combined results with a systematic review and meta-analysis of seven studies. In the registry cohort, EVT was associated with greater odds of 90-day functional independence (adjusted odds ratio 8.46, 95% CI 2.29-31.17; p < 0.001), without a detected increase in symptomatic intracranial hemorrhage or death.

Key findings

  • In the BASILAR cohort, EVT was associated with higher odds of functional independence: adjusted odds ratio 8.46, 95% CI 2.29-31.17; p < 0.001.
  • Symptomatic intracranial hemorrhage occurred in 1.3% vs. 0%; death was not significantly associated with EVT (adjusted odds ratio 0.35, 95% CI 0.07-1.63, p = 0.18).
  • Across seven studies, EVT was associated with functional independence (pooled adjusted odds ratio 1.78, 95% CI 1.00-3.18; p = 0.05) and excellent outcomes (adjusted odds ratio 3.98, 95% CI 1.32-11.95; p = 0.01).

Why it matters

Basilar artery occlusion can have serious consequences, yet the role of thrombectomy in patients presenting with mild deficits is uncertain. These findings add comparative and pooled evidence suggesting a possible functional benefit without an observed increase in symptomatic intracranial hemorrhage or mortality. The results may inform clinical discussion, while the non-randomised evidence and call for randomized validation warrant caution.

What to keep in mind

The registry comparison was observational, despite adjustment for baseline imbalances; the authors state that randomized trials are needed to validate the findings.

Source

Published in Neurol Res. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Neurology

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.